Sandrock Alfred
Voyager Therapeutics, Inc. · President and CEO
Sandrock Alfred is listed in filings as President and CEO at Voyager Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 3, 2026, including sale activity. Recent filings connect the profile to Voyager Therapeutics, Inc. (VYGR). The current snapshot covers public activity from Feb 12, 2025 to Apr 3, 2026. Reported amounts are shown as $44.5K to $40.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $54k14.2k shares | SellFeb 24, 2026 | $3.79 | $3.93 | |
| $40k11.7k shares | SellFeb 18, 2026 | $3.41 | $3.93 | |
| $46k12.2k shares | SellFeb 10, 2026 | $3.78 | $3.93 | |
| $37k10.9k shares | SellApr 2, 2025 | $3.43 | $3.93 | |
| $50k11.7k shares | SellFeb 20, 2025 | $4.24 | $3.93 | |
| $74k16.6k shares | SellFeb 11, 2025 | $4.45 | $3.93 |